Education
About Us
Working with TipRanks
Follow Us
Rocket Pharmaceuticals (RCKT)
NASDAQ:RCKT
RCKT Analyst Ratings
Moderate Buy
9 Buy
7 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RCKT Stock 12 Month Forecast
Average Price Target
$10.75
▲(288.09%Upside)
| Highest Price Target$30.00 | Average Price Target$10.75 | Lowest Price Target$2.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Canaccord Genuity
$34→$11
Buy
297.11%
Upside
Reiterated
06/03/25
Evercore ISI
$5
Hold
80.51%
Upside
Downgraded
06/03/25
LifeSci Capital
$9
Buy
224.91%
Upside
Reiterated
05/31/25
Chardan Capital
$46→$17
Buy
513.72%
Upside
Reiterated
05/28/25
Bank of America Securities
$32→$9
Buy
224.91%
Upside
Reiterated
05/28/25
J.P. Morgan
$44→$7
Hold
152.71%
Upside
Downgraded
05/28/25
Jefferies
$29→$2.5
Hold
-9.75%
Downside
Downgraded
05/28/25
Goldman Sachs
$2
Sell
-27.80%
Downside
Downgraded
05/28/25
Scotiabank
$51→$19
Buy
585.92%
Upside
Reiterated
05/28/25
Morgan Stanley
$42→$7
Hold
152.71%
Upside
Downgraded
05/28/25
Leerink Partners
$37→$8
Hold
188.81%
Upside
Downgraded
05/28/25
William Blair
―
Buy
―
Reiterated
05/27/25
TD Cowen
―
Hold
―
Downgraded
05/27/25
Needham
―
Hold
―
Downgraded
05/27/25
Wedbush
$32→$16
Buy
477.62%
Upside
Reiterated
05/27/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Canaccord Genuity
$34→$11
Buy
297.11%
Upside
Reiterated
06/03/25
Evercore ISI
$5
Hold
80.51%
Upside
Downgraded
06/03/25
LifeSci Capital
$9
Buy
224.91%
Upside
Reiterated
05/31/25
Chardan Capital
$46→$17
Buy
513.72%
Upside
Reiterated
05/28/25
Bank of America Securities
$32→$9
Buy
224.91%
Upside
Reiterated
05/28/25
J.P. Morgan
$44→$7
Hold
152.71%
Upside
Downgraded
05/28/25
Jefferies
$29→$2.5
Hold
-9.75%
Downside
Downgraded
05/28/25
Goldman Sachs
$2
Sell
-27.80%
Downside
Downgraded
05/28/25
Scotiabank
$51→$19
Buy
585.92%
Upside
Reiterated
05/28/25
Morgan Stanley
$42→$7
Hold
152.71%
Upside
Downgraded
05/28/25
Leerink Partners
$37→$8
Hold
188.81%
Upside
Downgraded
05/28/25
William Blair
―
Buy
―
Reiterated
05/27/25
TD Cowen
―
Hold
―
Downgraded
05/27/25
Needham
―
Hold
―
Downgraded
05/27/25
Wedbush
$32→$16
Buy
477.62%
Upside
Reiterated
05/27/25
Best Analysts Covering Rocket Pharmaceuticals
1 Month
xxx
Success Rate
14/24 ratings generated profit
Average Return
+5.81%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 58.33% of your transactions generating a profit, with an average return of +5.81% per trade.
3 Months
xxx
Success Rate
14/24 ratings generated profit
Average Return
+14.08%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +14.08% per trade.
1 Year
Success Rate
14/24 ratings generated profit
Average Return
+20.39%
reiterated a buy rating 10 days ago
Copying Geulah Livshits's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +20.39% per trade.
2 Years
xxx
Success Rate
3/11 ratings generated profit
Average Return
-35.69%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 27.27% of your transactions generating a profit, with an average return of -35.69% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RCKT Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
18
17
15
31
29
Buy
2
2
2
5
5
Hold
1
1
1
9
10
Sell
0
0
0
1
1
Strong Sell
0
0
0
0
0
total
21
20
18
46
45
Each month's total comprises the sum of three months' worth of ratings.
RCKT Financial Forecast
RCKT Stock Forecast FAQ
What is RCKT’s average 12-month price target, according to analysts?
Based on analyst ratings, Rocket Pharmaceuticals’s 12-month average price target is 10.75.
What is RCKT’s upside potential, based on the analysts’ average price target?
Rocket Pharmaceuticals has 288.09% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RCKT a Buy, Sell or Hold?
Rocket Pharmaceuticals has a consensus rating of Moderate Buy which is based on 9 buy ratings, 7 hold ratings and 1 sell ratings.
What is Rocket Pharmaceuticals’s price target?
The average price target for Rocket Pharmaceuticals is 10.75. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.00 ,the lowest forecast is $2.00. The average price target represents 288.09% Increase from the current price of $2.77.
The highest analyst price target is $30.00 ,the lowest forecast is $2.00. The average price target represents 288.09% Increase from the current price of $2.77.
What do analysts say about Rocket Pharmaceuticals?
Rocket Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.
How can I buy shares of RCKT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.